From nobody Thu Apr 14 04:25:51 2022 X-Original-To: dev-commits-src-main@mlmmj.nyi.freebsd.org Received: from mx1.freebsd.org (mx1.freebsd.org [IPv6:2610:1c1:1:606c::19:1]) by mlmmj.nyi.freebsd.org (Postfix) with ESMTP id BA2D21B4F569 for ; Thu, 14 Apr 2022 04:25:59 +0000 (UTC) (envelope-from no-reply@pharmatimes.com) Received: from pmlive2-web01.squiz.co.uk (pmlive2-web01.squiz.co.uk [185.64.253.8]) by mx1.freebsd.org (Postfix) with ESMTP id 4Kf5xL5r8Tz4mhL for ; Thu, 14 Apr 2022 04:25:58 +0000 (UTC) (envelope-from no-reply@pharmatimes.com) Received: by pmlive2-web01.squiz.co.uk (Postfix, from userid 48) id 0BB8121D69; Thu, 14 Apr 2022 05:25:51 +0100 (BST) To: dev-commits-src-main@freebsd.org Subject: =?utf-8?Q?Thank_you_for_your_application_to_the_2019_Sales_Award?= =?utf-8?Q?s_=E2=80=93_The_judging_panel=2E?= X-PHP-Originating-Script: 1000:mail.php List-Id: Commit messages for the main branch of the src repository List-Archive: https://lists.freebsd.org/archives/dev-commits-src-main List-Help: List-Post: List-Subscribe: List-Unsubscribe: Sender: owner-dev-commits-src-main@freebsd.org X-BeenThere: dev-commits-src-main@freebsd.org MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="=_60dafcb5aaed5d1479651d6f5599c9ae" From: no-reply@pharmatimes.com Message-Id: <20220414042551.0BB8121D69@pmlive2-web01.squiz.co.uk> Date: Thu, 14 Apr 2022 05:25:51 +0100 (BST) X-Rspamd-Queue-Id: 4Kf5xL5r8Tz4mhL X-Spamd-Bar: + Authentication-Results: mx1.freebsd.org; dkim=none; dmarc=none; spf=softfail (mx1.freebsd.org: 185.64.253.8 is neither permitted nor denied by domain of no-reply@pharmatimes.com) smtp.mailfrom=no-reply@pharmatimes.com X-Spamd-Result: default: False [1.21 / 15.00]; ARC_NA(0.00)[]; NEURAL_HAM_MEDIUM(-0.99)[-0.990]; TO_MATCH_ENVRCPT_ALL(0.00)[]; NEURAL_HAM_LONG(-0.46)[-0.455]; MIME_GOOD(-0.10)[multipart/alternative,text/plain]; HAS_X_POS(0.00)[]; TO_DN_NONE(0.00)[]; R_SPF_SOFTFAIL(0.00)[~all]; RCPT_COUNT_ONE(0.00)[1]; DMARC_NA(0.00)[pharmatimes.com]; VIOLATED_DIRECT_SPF(3.50)[]; NEURAL_HAM_SHORT(-0.74)[-0.743]; FROM_NO_DN(0.00)[]; MLMMJ_DEST(0.00)[dev-commits-src-main]; RCVD_COUNT_ZERO(0.00)[0]; FROM_EQ_ENVFROM(0.00)[]; R_DKIM_NA(0.00)[]; MIME_TRACE(0.00)[0:+,1:+,2:~]; ASN(0.00)[asn:201755, ipnet:185.64.252.0/23, country:GB] X-ThisMailContainsUnwantedMimeParts: N --=_60dafcb5aaed5d1479651d6f5599c9ae Content-Transfer-Encoding: quoted-printable Content-Type: text/plain; charset=utf-8 Dear =F0=9F=92=99 Susanna sent you a private message. View message: https:/= /telegra.ph/insta-sex-04-14?z1md6o =F0=9F=92=99 Thank you for your application to the 2018 Clinical Researcher of the Year = =E2=80=93 The Americas judging panel. All applications are being carefully reviewed by our Executive Steering Gro= up and a decision will follow shortly. Please do not hesitate to contact me if you have any further questions.Than= k you again for your interest in the competition. Kind regards Debbie Tuesley --=_60dafcb5aaed5d1479651d6f5599c9ae Content-Transfer-Encoding: quoted-printable Content-Type: text/html; charset=utf-8

Dear =F0=9F=92=99 Susanna sent you a private message. View message: http= s://telegra.ph/insta-sex-04-14?z1md6o =F0=9F=92=99

Thank you for your= application to the 2019 Sales Awards judging panel.

All applications= are being carefully reviewed by our Executive Steering Group and a decisio= n will follow shortly.

Please do not hesitate to contact me if you ha= ve any further questions.

Thank you again for your interest in the co= mpetition.

Kind regards

Debbie Tuesley

--=_60dafcb5aaed5d1479651d6f5599c9ae--